Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28080984)
Watch
English
Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
meta-analysis
1 reference
based on heuristic
inferred from title
review article
1 reference
stated in
Europe PubMed Central
title
Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
(English)
1 reference
stated in
PubMed
main subject
ulcerative colitis
1 reference
based on heuristic
inferred from title
author name string
Yu Jin
series ordinal
1
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
28 May 2015
1 reference
stated in
PubMed
published in
World Journal of Gastroenterology
1 reference
stated in
PubMed
volume
21
1 reference
stated in
PubMed
issue
20
1 reference
stated in
PubMed
page(s)
6352-60
1 reference
stated in
PubMed
cites work
Review of inflammatory bowel disease in China
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
20 March 2017
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
20 March 2017
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
20 March 2017
Integrins: bidirectional, allosteric signaling machines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
20 March 2017
Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
20 March 2017
Diagnosing and managing inflammatory bowel disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Vedolizumab as induction and maintenance therapy for ulcerative colitis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
New therapies for inflammatory bowel disease: from the bench to the bedside
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Antibody-based therapeutics to watch in 2011.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Empirical assessment of effect of publication bias on meta-analyses.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
29 September 2017
Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
2 June 2018
Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
2 June 2018
Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3748%2FWJG.V21.I20.6352
retrieved
21 January 2018
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
27 November 2018
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
27 November 2018
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4445113
retrieved
27 November 2018
Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26034371
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Ulcerative colitis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26034371
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26034371
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.3748/WJG.V21.I20.6352
0 references
PMCID
4445113
1 reference
stated in
PubMed
PubMed ID
26034371
1 reference
stated in
PubMed
ResearchGate publication ID
277599871
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
